Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Completed

Plain-English translation of NCT02595866 on ClinicalTrials.gov ↗ · Source last updated August 2024 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(12 sites)

United States

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Zuckerberg San Francisco General Hospital, San Francisco, California

UCSF Medical Center-Parnassus, San Francisco, California

Yale University, New Haven, Connecticut

Louisiana State University Health Science Center, New Orleans, Louisiana